New
Acclinate
The AI engine Fit Assessment
BetaThe company will be attending ViVE 2025 Event
Blurb
Acclinate is a digital health company helping pharma diversify clinical trials by accessing and engaging communities of color.
HQ Location
Birmingham (United States)
Founded
2020
Employees
1 - 10
Total funding raised
$13.46M
Last Funding Event
Series A, $7.00M, May 7, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of a digital health platform designed to facilitate an increase in representation and diversity of their genomic research and clinical trials. The company's platform utilizes machine learning and predictive analytics to automate the identification, education, engagement and retention of willing and diverse genomic research and clinical trial participants, enabling biopharmaceutical research organizations to decrease the overall cost of drug development.